Several animal viruses encode proteins that bind double-stranded RNA (dsRNA) to counteract host dsRNA-dependent antiviral responses. This article discusses the structure and function of the dsRNA-binding proteins of influenza A virus and Ebola viruses (EBOVs).
Get full access to this article
View all access options for this article.
References
1.
AraminiJM, MaLC, ZhouL, SchauderCM, HamiltonK, AmerBR, MackTR, LeeHW, CiccosantiCT, ZhaoL, et al.2011. Dimer interface of the effector domain of non-structural protein 1 from influenza A virus: an interface with multiple functions. J Biol Chem, 286:26050–26060.
2.
BaleS, JulienJP, BornholdtZA, KroisAS, WilsonIA, SaphireEO. 2013. Ebolavirus VP35 coats the backbone of double-stranded RNA for interferon antagonism. J Virol, 87:10385–10388.
3.
BaslerCF, MikulasovaA, Martinez-SobridoL, ParagasJ, MuhlbergerE, BrayM, KlenkHD, PaleseP, Garcia-SastreA. 2003. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol, 77:7945–7956.
4.
CardenasWB, LooYM, GaleMJr., HartmanAL, KimberlinCR, Martinez-SobridoL, SaphireEO, BaslerCF. 2006. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J Virol, 80:5168–5178.
5.
ChangHW, JacobsBL. 1993. Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA. Virology, 194:537–547.
6.
ChengA, WongSM, YuanYA. 2009. Structural basis for dsRNA recognition by NS1 protein of influenza A virus. Cell Res, 19:187–195.
7.
ChienCY, TejeroR, HuangY, ZimmermanDE, RiosCB, KrugRM, MontelioneGT. 1997. A novel RNA-binding motif in influenza A virus non-structural protein 1. Nat Struct Biol, 4:891–895.
8.
ChienCY, XuY, XiaoR, AraminiJM, SahasrabudhePV, KrugRM, MontelioneGT. 2004. Biophysical characterization of the complex between double-stranded RNA and the N-terminal domain of the NS1 protein from influenza A virus: evidence for a novel RNA-binding mode. Biochemistry, 43:1950–1962.
9.
GackMU, AlbrechtRA, UranoT, InnKS, HuangIC, CarneroE, FarzanM, InoueS, JungJU, Garcia-SastreA. (2009). Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe, 5:439–449.
10.
GaleMJr., KatzeMG. 1998. Molecular mechanisms of interferon resistance mediated by viral-directed inhibition of PKR, the interferon-induced protein kinase. Pharmacol Ther, 78:29–46.
11.
GeisbertTW, HensleyLE. 2004. Ebola virus: new insights into disease aetiopathology and possible therapeutic interventions. Expert Rev Mol Med, 6:1–24.
12.
GreenspanD, PaleseP, KrystalM. 1988. Two nuclear location signals in the influenza virus NS1 nonstructural protein. J Virol, 62:3020–3026.
13.
HartmanAL, BirdBH, TownerJS, AntoniadouZA, ZakiSR, NicholST. 2008a. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus. J Virol, 82:2699–2704.
14.
HartmanAL, LingL, NicholST, HibberdML. 2008b. Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein. J Virol, 82:5348–5358.
15.
HartmanAL, TownerJS, NicholST. 2004. A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus. Virology, 328:177–184.
16.
HartmannR, JustesenJ, SarkarSN, SenGC, YeeVC. 2003. Crystal structure of the 2'-specific and double-stranded RNA-activated interferon-induced antiviral protein 2'-5'-oligoadenylate synthetase. Mol Cell, 12:1173–1185.
17.
HastieKM, BaleS, KimberlinCR, SaphireEO. 2012. Hiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses. Curr Opin Virol, 2:151–156.
18.
HatadaE, FukudaR. 1992. Binding of influenza A virus NS1 protein to dsRNA in vitro. J Gen Virol, 73:3325–3329.
19.
ImaniF, JacobsBL. 1988. Inhibitory activity of the interferon-induced protein kinase is associated with the reovirus serotype 1 s3 protein. Proc Natl Acad Sci U S A, 88:7887–7891.
20.
JiangF, RamanathanA, MillerMT, TangGQ, GaleMJr., PatelSS, MarcotrigianoJ. 2011. Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature, 479:423–427.
21.
KerryPS, AyllonJ, TaylorMA, HassC, LewisA, Garcia-SastreA, RandallRE, HaleBG, RussellRJ. 2011. A transient homotypic interaction model for the influenza A virus NS1 protein effector domain. PLoS One, 6:e17946
22.
KimberlinCR, BornholdtZA, LiS, WoodsVLJr., MacRaeIJ, SaphireEO. 2010. Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. Proc Natl Acad Sci U S A, 107:314–319.
23.
KowalinskiE, LunardiT, McCarthyAA, LouberJ, BrunelJ, GrigorovB, GerlierD, CusackS. 2011. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell, 147:423–435.
24.
KrugRM, FodorE. 2013. The virus genome and its replication. In: WebsterRG, BracialeTJ, LambRA, editors. Influenza textbook, 2nd ed. Hoboken (NJ): Wiley-Blackwell, p 57–66.
25.
KrugRM, Garcia-SastreA. 2013. The NS1 protein: a master regulator of host and viral functions. In: WebsterRG, BracialeTJ, LambRA, editors. Influenza textbook, 2nd ed. Hoboken (NJ): Wiley-Blackwell, p 114–132.
26.
LeungDW, PrinsKC, BorekDM, FarahbakhshM, TufarielloJM, RamananP, NixJC, HelgesonLA, OtwinowskiZ, HonzatkoRB, et al.2010. Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35. Nat Struct Mol Biol, 17:165–172.
27.
LiuJ, LynchPA, ChienCY, MontelioneGT, KrugRM, BermanHM. 1997. Crystal structure of the unique RNA-binding domain of the influenza virus NS1 protein. Nat Struct Biol, 4:896–899.
28.
LuY, WambachM, KatzeMG, KrugRM. 1995. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology, 214:222–228.
29.
MelenK, KinnunenL, FagerlundR, IkonenN, TwuKY, KrugRM, JulkunenI. 2007. Nuclear and nucleolar targeting of influenza A virus NS1 protein: striking differences between different virus subtypes. J Virol, 81:5995–6006.
30.
MinJ-Y, KrugRM. 2006. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: inhibiting the 2'-5' OAS/RNase L pathway. Proc Natl Acad Sci U S A, 103:7100–7105.
31.
PrinsKC, DelpeutS, LeungDW, ReynardO, VolchkovaVA, ReidSP, RamananP, CardenasWB, AmarasingheGK, VolchkovVE, et al.2010. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs. J Virol, 84:3004–3015.
32.
RobbNC, ChaseG, BierK, VreedeFT, ShawPC, NaffakhN, SchwemmleM, FodorE. 2011. The influenza A virus NS1 protein interacts with the nucleoprotein of viral ribonucleoprotein complexes. J Virol, 85:5228–5231.
33.
SilvermanRH. 1994. Fascination with 2-5A-dependent RNase: a unique enzyme that functions in interferon action. J Interferon Res, 14:101–104.
34.
SilvermanRH. 2007. Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response. J Virol, 81:12720–12729.
35.
TalonJ, HorvathCM, PolleyR, BaslerCF, MusterT, PaleseP, Garcia-SastreA. 2000. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol, 74:7989–7996.
36.
WangW, RiedelK, LynchK, ChienC, MontelioneGT, KrugRM. 1999. RNA-binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA, 5:195–205.
37.
WangX, LiM, ZhengH, MusterT, PaleseP, BegAA, Garcia-SastreA. 2000. Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol, 74:11566–11573.
38.
WiseHM, HutchinsonEC, JaggerBW, StuartAD, KangZH, RobbN, SchwartzmanLM, KashJC, FodorE, FirthAE, et al.2012. Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. PLoS Pathog, 8:e1002998
39.
WrightP, NeumannG, Kawaoka. 2012. Orthomyxoviruses. In: KnipeDM, HowleyPM, editors. Fields virology, 6th ed. Philadelphia (PA): Lippincott Williams & Wilkins, p 1186–1243.
40.
ZinzulaL, EspositoF, PalaD, TramontanoE. 2012. dsRNA binding characterization of full length recombinant wild type and mutants Zaire ebolavirus VP35. Antiviral Res, 93:354–363.
